prescription drugs
-
US Prescription Drug Costs More Than Double Those in Canada
Increasingly, patients in the U.S. look to Canada for more affordable prescription options since the Canadian government regulates drug costs. Some companies have noticed and are beginning to capitalize on the demand.
-
Here Are 8 Trends for Large Employers
A new Business Group on Health survey revealed several key trends for large, self-insured employers. These trends show a rising prevalence of mental health challenges and a decreasing emphasis on virtual health.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
CMS Anticipates a 1.8% Decrease in Medicare Part D Monthly Premiums for 2024
The average total monthly premium for Medicare Part D coverage is expected to be $55.50 in 2024, down from $56.49 in 2023, according to CMS.
-
Consumer / Employer, Health Tech
GoodRx Launches Solution To Help Consumers Manage Their Prescriptions
Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.
-
Nearly 2,000 Organizations Urge Congress to Pass PBM Reform
A coalition of nearly 2,000 employers, patient advocates, pharmacies, providers and businesses sent a letter to Congress on Wednesday urging the passage of legislation that would reform PBM practices.
-
Express Scripts Launches New Solutions To Advance Drug Price Transparency
Express Scripts released several new solutions last week that aim to improve drug price transparency, including a cap on out-of-pocket costs for prescription drugs for consumers. The news comes amid increasing scrutiny against pharmacy benefit managers.
-
Survey: More than Half of Payers Use Outcomes-based Contracts
About 58% of health plans had at least one outcomes-based contract for prescription drugs in 2022, an Avalere Health survey found. More than 35% had more than 10 outcomes-based contracts in 2022.
-
Making Pharmacy Benefits Transparent and Returning Control to Patients and Employers
Transcarent wants to transform the digital pharmacy benefit experience, enabling self-insured employers and their staff to make more informed choices.
-
GoodRx goes ‘provider mode’ with new platform
GoodRx is arguably most well-known for its search platform that allows consumers to compare drug prices across different pharmacies. Now, it has launched a similar platform for healthcare providers. The new platform, called “Provider Mode,” is designed to help providers search for drug cost information while they are conducting appointments with their patients.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
HHS: Prescription drug costs have skyrocketed in recent years
From July 2021 to July 2022, 1,216 prescription drugs saw price increases that soared past the inflation rate of 8.5% for that time period, one HHS report showed. Another reported that in 2021, the American healthcare system spent $603 billion on prescription drugs, of which $421 billion was spent on retail drugs.
-
Health plans, this is why real-time benefit tools have let you down
Every health plan is required to use real-time benefit tools, which allow physicians to access drug pricing and a patient’s benefit information at the point of care. But, to date, RTBTs haven’t delivered on the promised savings.
-
3 forecasts for the PBM industry in 2022
The current landscape heading into 2022 will keep pharmacy benefits under the microscope. Plan sponsors will evaluate their PBM’s pricing model to determine if their contract will deliver predictable costs, more opportunities for increased savings and improved care for their members.
-
First half of 2018 sees 18.7M pills and $164M lost due to drug diversion
These numbers compare to 2017, when 20.9 million pills and $301.1 million were lost because of drug diversion, according to an analysis by data analytics company Protenus.
-
Rising prescription drug costs are hitting many consumers hard – what are some potential solutions?
With helpful online resources and even a new mobile app, consumers can find ways to not let rising prescription drug costs take them down.